{
  "title": "New Patient Outcome Assessed in Psoriasis Biologic Trial - Medscape",
  "url": "https://www.medscape.com/viewarticle/move-toward-assessing-well-being-psoriasis-biologic-2025a1000rgw",
  "summary": [
    {
      "type": "bullet",
      "text": "**KEY FINDING**: Mean WHO-5 scores improved from 53.7 to 70.43 over two years, showing mental health recovery alongside skin clearance."
    },
    {
      "type": "bullet",
      "text": "**TACTICAL WIN [SHIP NOW]**: Use adaptive trial designs to incorporate patient-reported outcomes as primary endpoints early in development."
    },
    {
      "type": "bullet",
      "text": "**MARKET SIGNAL [ðŸŸ¡ NOTABLE]**: Growing regulatory push for PROs in clinical trials; FDA expects them within 12 months of submission."
    },
    {
      "type": "bullet",
      "text": "**CONCERN**: Self-selection bias may affect the validity of PRO results, potentially overestimating benefits."
    }
  ],
  "model": "granite4:tiny-h"
}